India's Mid-Market May 2026: Fintech, Synbio, and Deeptech Series A/B Deals
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
2026 venture capital activity reflects a market balancing AI infrastructure bets, selective growth equity, and renewed interest in capital-efficient startups. Our coverage tracks the rounds, fund launches, and strategic shifts that matter for founders and investors.
Read the latest 2026 VC news and funding roundups below.
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
European tech funding rebounded to €10.5B in May 2026 as mega-rounds powered a market recovery led by defense, deeptech, and sovereign technology.
May 2026 was the second-largest venture month on record — but strip out Anthropic's $50B and the real story is concentration, defense, and the reopening exit window.
D2C food brand Anveshan raised ₹121 crore (~$12.7M) Series B led by Vertex Ventures and IFC in May 2026, roughly doubling its valuation on a rural-sourcing model.
C2i Semiconductors raised a $16.7M Series A extension led by TDK Ventures and Peak XV in May 2026, advancing India's push into semiconductor design.
Corgi Insurance stacked a $160M Series B and a $106M Series B1 within weeks in May 2026, reaching a $2.6B valuation for its AI-native insurance platform.